List of insiders holdings for ARS Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
1 | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt III L.P. Deerfield Private Design Fund III L.P. Deerfield Mgmt IV L.P. Deerfield Private Design Fund IV L.P. 10% Owner |
2025-03-24 19:57:55 | 10,514,657 0 |
10,514,657 | Form 13D |
2 | Thompson Peter A. Director |
2024-08-28 16:30:07 | 0 8,288,510 |
8,288,510 | Form 4 |
3 | ORBIMED ADVISORS LLC OrbiMed Capital GP VI LLC ORBIMED CAPITAL LLC Director |
2024-08-28 16:26:15 | 0 8,288,510 |
8,288,510 | Form 4 |
4 | Shah Pratik Pratik Shah Living Trust dated June 15 2011 Director 10% Owner |
2024-06-17 20:47:57 | 5,219,124 0 |
5,219,124 | Form 13D |
5 | Schroeder Thilo Director |
2020-12-08 20:48:12 | 0 1,910,029 |
1,910,029 | Form 4 |
6 | Tanimoto Sarina CHIEF MEDICAL OFFICER 10% Owner |
2025-01-03 16:30:43 | 261,900 767,600 |
1,029,500 | Form 4 |
7 | Lowenthal Richard E PRESIDENT AND CEO 10% Owner |
2025-01-03 16:30:37 | 767,600 261,900 |
1,029,500 | Form 4 |
8 | Alexandria Venture Investments LLC 10% Owner |
2020-12-08 16:36:52 | 699,412 0 |
699,412 | Form 4 |
9 | Karas Eric Chief Commercial Officer |
2025-03-21 18:30:14 | 582,284 0 |
582,284 | Form 4 |
10 | Pepe Jeffrey C. Interim CEO and GC |
2022-09-08 17:04:48 | 427,750 0 |
427,750 | Form 3 |
11 | Shawver Laura Director |
2025-04-08 16:45:04 | 285,963 0 |
285,963 | Form 4 |
12 | Chakma Justin Chief Business Officer |
2025-01-03 16:30:36 | 274,100 0 |
274,100 | Form 4 |
13 | Dorsey Brian Chief Operating Officer |
2025-01-03 16:30:44 | 261,900 0 |
261,900 | Form 4 |
14 | Scott Kathleen D. Chief Financial Officer |
2025-01-03 16:30:33 | 176,700 0 |
176,700 | Form 4 |
15 | Piazza Jonathan Chief Financial Officer |
2022-05-04 17:16:04 | 156,608 0 |
156,608 | Form 4 |
16 | Fitzpatrick Alexander A Chief Legal Officer |
2025-01-03 16:30:47 | 152,300 0 |
152,300 | Form 4 |
17 | Odegard Valerie President and CSO |
2022-05-04 17:12:32 | 152,106 0 |
152,106 | Form 4 |
18 | Hunder Naomi Chief Medical Officer |
2022-05-04 17:07:01 | 140,782 0 |
140,782 | Form 4 |
19 | Presidio Management Group XII L.L.C. U.S. Venture Partners XII L.P. U.S. Venture Partners XII-A L.P. Tansey Casey M 10% Owner |
2022-01-27 15:05:08 | 110,120 0 |
110,120 | Form 13D |
20 | Hawkinson Russ Sr. Vice President of Finance |
2022-05-04 17:00:02 | 93,921 0 |
93,921 | Form 4 |
21 | Shah Pratik Director |
2024-06-24 17:00:19 | 40,000 0 |
40,000 | Form 4 |
22 | Dadoo Rajeev Director |
2024-06-24 17:06:22 | 40,000 0 |
40,000 | Form 4 |
23 | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner |
2024-06-24 17:13:43 | 0 40,000 |
40,000 | Form 4 |
24 | SCHNEIDER PHILLIP M Director |
2024-06-24 17:00:17 | 40,000 0 |
40,000 | Form 4 |
25 | Islam Saqib Director |
2024-06-24 17:00:16 | 40,000 0 |
40,000 | Form 4 |
26 | Kelly Michael Director |
2024-06-24 17:00:12 | 40,000 0 |
40,000 | Form 4 |
27 | SAUNDERS BRENT L Director |
2024-06-24 17:00:07 | 40,000 0 |
40,000 | Form 4 |
28 | HERSHBERG ROBERT Director |
2022-06-13 19:31:19 | 18,000 0 |
18,000 | Form 4 |
29 | CAPPS VICKIE L Director |
2022-06-13 19:27:09 | 18,000 0 |
18,000 | Form 4 |
30 | ROOT JONATHAN D Director |
2022-06-13 19:48:06 | 18,000 0 |
18,000 | Form 4 |
31 | Koehler Maria Director |
2022-06-13 19:39:13 | 18,000 0 |
18,000 | Form 4 |
32 | Powell Andrew Kenneth William Director |
2022-06-13 19:44:15 | 18,000 0 |
18,000 | Form 4 |
33 | LEFF JONATHAN S Director |
2022-11-10 17:00:26 | 0 0 |
0 | Form 3 |